MIMOCT: Min Implants Max Outcomes Clinical Trial

Sponsor
University of Minnesota (Other)
Overall Status
Completed
CT.gov ID
NCT01792609
Collaborator
Alfred I. duPont Hospital for Children (Other), Texas Scottish Rite Hospital for Children (Other), Johns Hopkins University (Other), University of Rochester (Other), Washington University School of Medicine (Other), Children's Hospital Colorado (Other), Mayo Clinic (Other), University of Iowa (Other), Norton Leatherman Spine Center (Other), Children's Hospital of Philadelphia (Other), St. Justine's Hospital (Other)
200
14
2
73.4
14.3
0.2

Study Details

Study Description

Brief Summary

Objectives Primary objective: Determine if there is a clinically significant difference in percent Cobb curve correction in a low- vs. high-implant density cohort through a prospective randomized controlled trial.

Design and Outcomes Randomized clinical trial of equivalence to test the efficacy and safety of low vs. high implant density instrumentation for spine deformity surgery in AIS patients with Lenke IA curve patterns.

Interventions and Duration Intervention: low-implant density group or high-implant density group. Duration: 2 years. Sample Size and Population Target population: 10 to 17 years old with AIS who will undergo instrumented spinal fusion. Sample size needed (power = 90%) is 174 subjects with 87 in each group.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Maximum Number of Screws
  • Procedure: Minimum Number of Screws
N/A

Detailed Description

The MIMO Study Group proposes to conduct a prospective randomized controlled trial in order to determine whether a low implant density cohort has equivalent clinical and radiographic results to a high implant density cohort. This study is proposed as a trial of equivalence. The null hypothesis is that significant differences exist in percent major Cobb angle correction between high- and low-implant density cohorts for Lenke 1A curve types, the most common scoliotic curve pattern (73). Consecutive qualifying patients will be screened and enrolled by high-volume spine surgeons at 14 sites and randomized to spinal instrumentation with a low- or high-density screw pattern. Patients will return at 3-months, 1-year, and 2-years for exam, radiographs, and collection of patient-reported outcome scores. The Harms Study Group Foundation will serve as a collaborating organization and will provide database development and management, secure online data collection, centralized radiographic measurements, and data quality control. The University of Minnesota team will lead study design, protocol development, IRB/data use agreement contracts, patient randomization, and statistical analysis, including quarterly data review. Imaging will be obtained either with an EOS system or using a calibration belt during the radiographs, which allows for subsequent with the 3D modeling of the deformity. Six enrolling sites currently have this capability (EOS - Montreal, St. Louis, Iowa, Mayo, DuPont, and San Diego). An additional five sites already have calibration belts - Dallas, New York, Baltimore, Boston, U. of Rochester), and new calibration belts will be fabricated for the additional sites. The Montreal site will supervise collection of radiographic data with 3D capability and assist with troubleshooting and radiographic quality control. Although the study is primarily powered to detect change in percent correction of the major coronal curve, preliminary data will be gathered on axial and sagittal plane correction as well as complications, surgical factors, and patient-reported outcomes.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Minimize Implants Maximize Outcomes (MIMO) Clinical Trial
Actual Study Start Date :
Apr 18, 2013
Actual Primary Completion Date :
Jun 1, 2019
Actual Study Completion Date :
Jun 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Maximum Number of Screws

Once enrolled and consented, patients with Lenke 1A curves will be randomized to a high- or low-density screw cohort. The high-density pattern will be designated as ≥ 1.8 implants per level fused. The low density pattern will be ≤ 1.4 screws per level fused. At least 75% of the implants must be pedicle screws for both cohorts.

Procedure: Maximum Number of Screws
The tools used for this arm of study are FDA approved with section 510 (k) K122433. These screws are regularly used in all procedures pertaining to Cobb angle correction surgeries outside of the context of this study.
Other Names:
  • Pedicle Screw Spinal System
  • Active Comparator: Minimum Number of Screws

    Once enrolled and consented, patients with Lenke 1A curves will be randomized to a high- or low-density screw cohort. The high-density pattern will be designated as ≥ 1.8 implants per level fused. The low density pattern will be ≤ 1.4 screws per level fused. At least 75% of the implants must be pedicle screws for both cohorts.

    Procedure: Minimum Number of Screws
    The tools used for this arm of study are FDA approved with section 510 (k) K122433. These screws are regularly used in all procedures pertaining to Cobb angle correction surgeries outside of the context of this study.
    Other Names:
  • Pedicle Screw Spinal System
  • Outcome Measures

    Primary Outcome Measures

    1. Change in Cobb Angle [pre-surgery ranging 1 year to 1 month and peri surgery at about 3-months, 1-year, and 2-year postoperative]

      Radiographic, surgical, and patient-reported data will be gathered and analyzed to observe changes between time points. All radiographs will be taken with 3D analysis capability, either with a calibration belt using standard radiograph techniques or with an EOS imaging system. This will allow for additional detailed correction measures, such as change in spinal rotation (orientation of the planes of maximum curvature) and detailed coronal, sagittal and transverse plane measures. Bending films will be taken according to institutional protocol. The SRS-30, SAQ, and EQ5D will be collected at all clinical visits. Study questions will be aligned as much as possible with other prospective scoliosis protocols so as to minimize patient and surgeon response burden. The study protocol requires no additional visits or radiographs beyond standard of care.

    Secondary Outcome Measures

    1. Blood Loss [During surgery, 1 time occurence]

      Blood loss amount that occured during the surgical procedure.

    2. Operative Time [1 time measurement, occurs at surgery]

      Length of time required to complete surgical procedure in either arm of the study (highest number or lowest number of screws).

    3. 3D parameter correction [collected during surgical procedure]

      Surgeon reported measure of screw manipulation during the surgery.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    10 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients aged ≥10 and ≤ 18 years

    • Male or Female

    • Diagnosis of idiopathic scoliosis for which surgery is recommended to prevent the curvature or to correct trunk disfigurement Lenke 1A curve pattern

    • Curve cobb of 45° to 65°

    • T5-T12 kyphosis measuring 0° to 40°

    • Spina bifida Oculta is permitted

    • Spondylolisthesis and Spondylolysis are permitted, as long as non- operative

    Exclusion Criteria:
    • Prior spinal surgery

    • MRI abnormalities (including >4mm of Syrinx and/or Chiari malformation)

    • Neuromuscular or other serious co-morbidities

    • Thoracogenic or cardiogenic scoliosis

    • Associated syndrome or developmental delay

    • Unable or unwilling to firmly commit to returning for required follow-up

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Children's Hospital Colorado Aurora Colorado United States 80045
    2 Nemours/ Alfred I. duPont Hospital for Children Wilmington Delaware United States 19803
    3 Children's Research Institute Washington District of Columbia United States 20010-2916
    4 University of Florida Gainesville Florida United States 32611
    5 Emory University Atlanta Georgia United States 30329
    6 University of Iowa Iowa City Iowa United States 52242
    7 Norton Leatherman Spine Center Louisville Kentucky United States 40207
    8 Johns Hopkins University Baltimore Maryland United States 21205
    9 University of Minnesota Minneapolis Minnesota United States 55454
    10 Mayo Clinic Rochester Minnesota United States 55905
    11 The Washington University in St. Louis Saint Louis Missouri United States 63110
    12 University of Rochester Rochester New York United States 14618
    13 Texas Scottish Rite Hospital for Children Dallas Texas United States 75219
    14 Centre Hospitalier Universitaire Sainte-Justine Montreal Quebec Canada H3T1C5

    Sponsors and Collaborators

    • University of Minnesota
    • Alfred I. duPont Hospital for Children
    • Texas Scottish Rite Hospital for Children
    • Johns Hopkins University
    • University of Rochester
    • Washington University School of Medicine
    • Children's Hospital Colorado
    • Mayo Clinic
    • University of Iowa
    • Norton Leatherman Spine Center
    • Children's Hospital of Philadelphia
    • St. Justine's Hospital

    Investigators

    • Principal Investigator: David W Polly, MD, University of Minnesota

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Minnesota
    ClinicalTrials.gov Identifier:
    NCT01792609
    Other Study ID Numbers:
    • 1208M18202
    First Posted:
    Feb 15, 2013
    Last Update Posted:
    Aug 3, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by University of Minnesota
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 3, 2022